Bulking agents for minimally invasive correction of stress urinary incontinence in women

Abstract

BACKGROUND: The study is relevant due to the widespread prevalence of stress urinary incontinence in women and the search for minimally invasive and safe treatment methods.

AIM: The aim of this study was to present data based on modern evidence-based information on the effectiveness of urethral bulking agents and their safety in stress urinary incontinence treatment in women.

MATERIALS AND METHODS: A review of the literature (original articles, systematic reviews) on the use of urethral bulking agents for stress urinary incontinence treatment in women was carried out.

RESULTS: Urethral bulking agents for stress urinary incontinence treatment are effective due to the creation of additional bulk in the paraurethral area without fibrosis or because of inflammation followed by fibrous tissue formation. The efficacy and complications depend on the properties of the used urethral bulking agents. Since the performed studies are heterogeneous and the methods for evaluating the use of bulking fillers in stress urinary incontinence treatment vary, it is difficult to comparatively characterize urethral bulking agents to determine the most effective one. The search is being conducted for an ideal proper filler, which should be biocompatible and non-immunogenic and maintain a long-term therapeutic effect.

CONCLUSIONS: Urethral bulking injections are an alternative therapy for women with stress urinary incontinence who are informed about its short-term effect and are expecting to avoid the risk of possible complications after surgery. Promising is to be regarded as the use of new urethral bulking agents based on hyaluronic acid with an optimal choice of concentration, degree of crosslinking and type of crosslinking agent to ensure maximum duration of action and minimum side effects.

Keywords

stress urinary incontinence / bulking agents / hyaluronic acid / surgical treatment / complications

References

[1] Almousa S, Bandin van Loon A. The prevalence of urinary incontinence in nulliparous adolescent and middle-aged women and the associated risk factors: A systematic review. Maturitas. 2018;107:78–83. DOI: 10.1016/j.maturitas.2017.10.003

[2] Almousa S., Bandin van Loon A. The prevalence of urinary incontinence in nulliparous adolescent and middle-aged women and the associated risk factors: A systematic review//Maturitas. 2018. Vol. 107. No. 78–83. DOI: 10.1016/j.maturitas.2017.10.003

[3] Rusina EI, Bezhenar VF, Ivashchenko TE, et al. The specific features of MMP1, MMP3, and PAI1 gene polymorphisms in patients with pelvic organ prolapse and stress urinary incontinence. Obstetrics and Gynecology 2014;(9):63–68. (In Russ.)

[4] Русина Е.И., Беженарь Е.Ф., Иващенко Т.Э. и др. Особенности полиморфизма генов MMP1, MMP3, PAI1 у больных с пролапсом тазовых органов и стрессовым недержанием мочи//Акушерство и гинекология. 2014. № 9. С. 63–68.

[5] Apolihina IA, Saidova IS. Stress urinary incontinence. Obstetrics and Gynecology. 2019(3 Suppl):20–25. (In Russ.)

[6] Аполихина И.А., Саидова А.С. Стрессовое недержание мочи//Акушерство и гинекология. 2019. № 3 (Прил.). С. 20–25.

[7] Abrams P, Smith AP, Cotterill N. The impact of urinary incontinence on health-related quality of life (HRQoL) in a real-world population of women aged 45-60 years: results from a survey in France, Germany, the UK and the USA. BJU Int. 2015;115(1):143–152. DOI: 10.1111/bju.12852

[8] Abrams P., Smith A.P., Cotterill N. The impact of urinary incontinence on health-related quality of life (HRQoL) in a real-world population of women aged 45-60 years: results from a survey in France, Germany, the UK and the USA//BJU Int. 2015. Vol. 115. No. 1. P. 143–152. DOI: 10.1111/bju.12852

[9] Kira KE, Bezhenar VF, Prokhorova VS. Urethrovesical segment ultrasound for the efficacy evaluation of surgical treatment of stress urinary incontinence. Journal of Obstetrics and Women’s Diseases. 2021;69(6):43–48. (In Russ.). DOI: 10.17816/JOWD69643-48

[10] Кира К.Е., Беженарь В.Ф., Прохоров В.С. Ультразвуковое исследование уретровезикального сегмента как метод оценки эффективности хирургического лечения стрессового недержания мочи//Журнал акушерства и женских болезней. 2020. Т. 69. № 6. С. 43–48. DOI: 10.17816/JOWD69643-48

[11] Zheleznyakova IA. Optimizaciya lecheniya stressovogo nederzhaniya mochi u zhenshchin s pomoshch’yu metoda ekstrakorporal’noj magnitnoj stimulyacii. [dissertation abstract]. Moscow; 2011. (In Russ.). [cited 2021 July 1]. Available from: https://www.dissercat.com/content/optimizatsiya-lecheniya-stressovogo-nederzhaniya-mochi-u-zhenshchin-s-pomoshchyu-metoda-ekst/readhttps://www.dissercat.com/content/optimizatsiya-lecheniya-stressovogo-nederzhaniya-mochi-u-zhenshchin-s-pomoshchyu-metoda-ekst/read

[12] Железнякова И.А. Оптимизация лечения стрессового недержания мочи у женщин с помощью метода экстракорпоральной магнитной стимуляции: автореф. дис. … мед. наук. Москва, 2011. [дата обращения 1.07.2021]. Доступ по ссылке: https://www.dissercat.com/content/optimizatsiya-lecheniya-stressovogo-nederzhaniya-mochi-u-zhenshchin-s-pomoshchyu-metoda-ekst/readhttps://www.dissercat.com/content/optimizatsiya-lecheniya-stressovogo-nederzhaniya-mochi-u-zhenshchin-s-pomoshchyu-metoda-ekst/read

[13] McGuire EJ. Pathophysiology of stress urinary incontinence. Rev Urol. 2004;6 Suppl 5(Suppl 5):S11–S17.

[14] McGuire E.J. Pathophysiology of stress urinary incontinence//Rev. Urol. 2004. Vol. 6. Suppl. 5. (Suppl. 5). P. S11–S17.

[15] Kirchin V, Page T, Keegan PE, et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database of Systematic Reviews. 2017;2017;7(7):1–67. DOI: 10.1002/14651858.CD003881.pub4

[16] Kirchin V., Page T., Keegan P.E. et al. Urethral injection therapy for urinary incontinence in women//Cochrane Database of Systematic Reviews. 2017. Vol. 7. No. 7. P. 1–67. DOI: 10.1002/14651858.CD003881.pub4

[17] Li H, Westney OL. Injection of urethral bulking agents. Urol Clin North Am. 2019;46(1):1–15. DOI: 10.1016/j.ucl.2018.08.012

[18] Li H., Westney O.L. Injection of urethral bulking agents//Urol. Clin. North Am. 2019. Vol. 46. No. 1. P. 1–15. DOI: 10.1016/j.ucl.2018.08.012

[19] Linder BJ, Elliott DS. Synthetic midurethral slings: roles, outcomes, and complications. Urologic Clinics of North America. 2019;46(1):17–30. DOI: 10.1016/j.ucl.2018.08.013

[20] Linder B.J., Elliott D.S. Synthetic midurethral slings: roles, outcomes, and complications//Urol. Clin. North Am. 2019. Vol. 46. No. 1. P. 17–30. DOI: 10.1016/j.ucl.2018.08.013

[21] Capobianco G, Saderi L, Dessole F, et al. Efficacy and effectiveness of bulking agents in the treatment of stress and mixed urinary incontinence: A systematic review and meta-analysis. Maturitas. 2020;133:13–31. DOI: 10.1016/j.maturitas.2019.12.007

[22] Capobianco G., Saderi L., Dessole F. et al. Efficacy and effectiveness of bulking agents in the treatment of stress and mixed urinary incontinence: A systematic review and meta-analysis//Maturitas. 2020. Vol. 133. P. 13–31. DOI: 10.1016/j.maturitas.2019.12.007

[23] Martin K, Emil S, Bernard C, et al. Dextranomer hyaluronic acid copolymer effects on gastroesophageal junction. J Pediatr Gastroenterol Nutr. 2014;58(5):593–597. DOI: 10.1097/MPG.0000000000000259

[24] Martin K., Emil S., Bernard C. et al. Dextranomer hyaluronic acid copolymer effects on gastroesophageal junction//J. Pediatr. Gastroenterol. Nutr. 2014. Vol. 58. No. 5. P. 593–597. DOI: 10.1097/MPG.0000000000000259

[25] Brown JE, Gulka CP, Giordano JEM, et al. Injectable silk protein microparticle-based fillers: A novel material for potential use in glottic insufficiency. J Voice. 2019;33(5):773–780. DOI: 10.1016/j.jvoice.2018.01.017

[26] Brown J.E., Gulka C.P., Giordano J.E.M. et al. Injectable silk protein microparticle-based fillers: A novel material for potential use in glottic insufficiency//J. Voice. 2019. Vol. 33. No. 5. P. 773–780. DOI: 10.1016/j.jvoice.2018.01.017

[27] Fallacara A, Manfredini S, Durini E, Vertuani S. Hyaluronic acid fillers in soft tissue regeneration. Facial Plast Surg. 2017;33(1):87–96. Corrected and republished from: Facial Plast Surg. 2017;33(2):244. DOI: 10.1055/s-0036-1597685

[28] Fallacara A., Manfredini S., Durini E., Vertuani S. Hyaluronic acid fillers in soft tissue regeneration//Facial. Plast. Surg. 2017. Vol. 33. No. 1. P. 87–96. Corrected and republished from: Facial. Plast Surg. 2017 Vol. 33. No. 2. P. 244. DOI: 10.1055/s-0036-1597685

[29] Parker R. The paraffin injection treatment of Gersuny with a report of cases. JAMA. 1902;XXXVIII(16):1000–1003. DOI: 10.1001/jama.1902.62480160022001d

[30] Parker R. The paraffin injection treatment of Gersuny with a report of cases//JAMA. 1902. Vol. XXXVIII. No. 16. P. 1000–1003. DOI: 10.1001/jama.1902.62480160022001d

[31] Murless B. The injection treatment of stress incontinence. Br J Obstet Gynaecol. 1938;45(1):521–524. DOI: 10.1111/j.1471-0528.1938.tb12430.x

[32] Murless B. The injection treatment of stress incontinence//Br. J. Obstet. Gynaecol. 1938. Vol. 45. No. 1. P. 521–524. DOI: 10.1111/j.1471-0528.1938.tb12430.x

[33] Chaliha C, Williams G. Periurethral injection therapy for the treatment of urinary incontinence. Br J Urol. 1995;76(2):151–155. DOI:10.1111/j.1464-410x.1995.tb07663.x

[34] Chaliha C., Williams G. Periurethral injection therapy for the treatment of urinary incontinence//Br. J. Urol. 1995. Vol. 76. No. 2. P. 151–155. DOI: 10.1111/j.1464-410x.1995.tb07663.x

[35] Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J Urol. 2001;165(1):153–158. DOI: 10.1097/00005392-200101000-00037

[36] Lee P.E., Kung R.C., Drutz H.P. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial//J. Urol. 2001. Vol. 165. No. 1. P. 153–158. DOI: 10.1097/00005392-200101000-00037

[37] Currie I, Drutz HP, Deck J, Oxorn D. Adipose tissue and lipid droplet embolism following periurethral injection of autologous fat: case report and review of the literature. Int Urogynecol J Pelvic Floor Dysfunct. 1997;8(6):377–380. DOI: 10.1007/BF02765599

[38] Currie I., Drutz H.P., Deck J., Oxorn D. Adipose tissue and lipid droplet embolism following periurethral injection of autologous fat: case report and review of the literature//Int. Urogynecol. J. Pelvic. Floor. Dysfunct. 1997. Vol. 8. No. 6. P. 377–380. DOI: 10.1007/BF02765599

[39] Sokol ER, Karram MM, Dmochowski R. Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study. J Urol. 2014;192(3):843–849. DOI: 10.1016/j.juro.2014.03.109

[40] Sokol E.R., Karram M.M., Dmochowski R. Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study//J. Urol. 2014. Vol. 192. No. 3. P. 843–849. DOI: 10.1016/j.juro.2014.03.109

[41] Gorton E, Stanton S, Monga A, et al. Periurethral collagen injection: a long-term follow-up study. BJU Int. 1999;84(9):966–971. DOI: 10.1046/j.1464-410x.1999.00321.x

[42] Gorton E., Stanton S., Monga A. et al. Periurethral collagen injection: a long-term follow-up study//BJU Int. 1999. Vol. 84. No. 9. P. 966–971. DOI: 10.1046/j.1464-410x.1999.00321.x

[43] Hurtado E, McCrery R, Appell R. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(8):869–873. DOI: 10.1007/s00192-006-0251-2

[44] Hurtado E., McCrery R., Appell R. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency//Int. Urogynecol. J. Pelvic. Floor Dysfunct. 2007. Vol. 18. No. 8. P. 869–873. DOI: 10.1007/s00192-006-0251-2

[45] Chapple C, Dmochowski R. Particulate versus non-particulate bulking agents in the treatment of stress urinary incontinence. Res Rep Urol. 2019;11:299–310. DOI: 10.2147/RRU.S220216

[46] Chapple C., Dmochowski R. Particulate versus non-particulate bulking agents in the treatment of stress urinary incontinence//Res. Rep. Urol. 2019. Vol. 11. P. 299–310. DOI: 10.2147/RRU.S220216

[47] Ghoniem GM, Miller CJ. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Int Urogynecol J. 2013;24(1):27–36. DOI: 10.1007/s00192-012-1825-9

[48] Ghoniem G.M., Miller C.J. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence//Int. Urogynecol. J. 2013. Vol. 24. No. 1. P. 27–36. DOI: 10.1007/s00192-012-1825-9

[49] Serati M, Soligo M, Braga A, et al. Efficacy and safety of polydimethylsiloxane injection (Macroplastique®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow-up. BJU Int. 2019;123(2):353–359. DOI: 10.1111/bju.14550

[50] Serati M., Soligo M., Braga A. et al. Efficacy and safety of polydimethylsiloxane injection (Macroplastique®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow-up//BJU Int. 2019. Vol. 123. No. 2. P. 353–359. DOI: 10.1111/bju.14550

[51] Carroll TF, Christie A, Foreman M, et al. Macroplastique for women with stress urinary incontinence secondary to intrinsic sphincter deficiency. Int Braz J Urol. 2019;45(5):989–998. DOI: 10.1590/S1677-5538.IBJU.2019.0070

[52] Carroll T.F., Christie A., Foreman M. et al. Macroplastique for women with stress urinary incontinence secondary to intrinsic sphincter deficiency//Int. Braz. J. Urol. 2019. Vol. 45. No. 5. P. 989–998. DOI: 10.1590/S1677-5538.IBJU.2019.0070

[53] Bennett AT, Lukacz ES. Two cases of suspected rejection of polydimethylsiloxane urethral bulking agent. Female Pelvic Med Reconstr Surg. 2017;23(3):e10–e11. DOI: 10.1097/SPV.0000000000000367

[54] Bennett A.T., Lukacz E.S. Two cases of suspected rejection of polydimethylsiloxane urethral bulking agent//Female Pelvic. Med. Reconstr. Surg. 2017. Vol. 23. No. 3. P. e10–e11. DOI: 10.1097/SPV.0000000000000367

[55] Rodríguez D, Jaffer A, Hilmy M, Zimmern P. Bladder neck and urethral erosions after Macroplastique injections. Low Urin Tract Symptoms. 2021;13(1):93–97. DOI: 10.1111/luts.12337

[56] Rodríguez D., Jaffer A., Hilmy M., Zimmern P. Bladder neck and urethral erosions after Macroplastique injections//Low Urin. Tract. Symptoms. 2021. Vol. 13. No. 1. P. 93–97. DOI: 10.1111/luts.12337

[57] Capobianco G, Azzena A, Saderi L, et al. Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2018;29(9):1239–1247. DOI: 10.1007/s00192-018-3703-6

[58] Capobianco G., Azzena A., Saderi L. et al. Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis//Int. Urogynecol. J. 2018. Vol. 29. No. 9. P. 1239–1247. DOI: 10.1007/s00192-018-3703-6

[59] de Vries AM, van Breda HMK, Fernandes JG, et al. Para-urethral injections with Urolastic® for treatment of female stress urinary incontinence: Subjective improvement and safety. Urol Int. 2017;99(1):91–97. DOI: 10.1159/000452450

[60] de Vries A.M., van Breda H.M.K., Fernandes J.G. et al. Para-urethral injections with Urolastic® for treatment of female stress urinary incontinence: Subjective improvement and safety//Urol. Int. 2017. Vol. 99. No. 1. P. 91–97. DOI: 10.1159/000452450

[61] Christensen LH, Nielsen JB, Mouritsen L, et al. Tissue integration of polyacrylamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig. Dermatol Surg. 2008;34(Suppl 1):S68–S77. DOI: 10.1111/j.1524-4725.2008.34246.x

[62] Christensen L.H., Nielsen J.B, Mouritsen L. et al. Tissue integration of polyacrylamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig//Dermatol. Surg. 2008. Vol. 34. Suppl. 1. P. S68–S77. DOI: 10.1111/j.1524-4725.2008.34246.x

[63] Kasi AD, Pergialiotis V, Perrea DN, et al. Polyacrylamide hydrogel (Bulkamid®) for stress urinary incontinence in women: a systematic review of the literature. Int Urogynecol J. 2016;27(3):367–375. DOI: 10.1007/s00192-015-2781-y

[64] Kasi A.D., Pergialiotis V., Perrea D.N. et al. Polyacrylamide hydrogel (Bulkamid®) for stress urinary incontinence in women: a systematic review of the literature//Int. Urogynecol. J. 2016. Vol. 27. No. 3. P. 367–375. DOI: 10.1007/s00192-015-2781-y

[65] Brosche T, Kuhn A, Lobodasch K, Sokol ER. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Neurourol Urodyn. 2021;40(1):502–508. DOI: 10.1002/nau.24589

[66] Brosche T., Kuhn A., Lobodasch K., Sokol E.R. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence//Neurourol. Urodyn. 2021. Vol. 40. No. 1. P. 502–508. DOI: 10.1002/nau.24589

[67] Sigaeva NN, Kolesov SV, Nazarov PV, Vildanova RR. Himicheskaya modifikatciya gialuronovoy kisloty i ee primenenie in meditsine. Vestnik Bashkirskogo Universiteta. 2012;17(3):1220–1241. (In Russ.)

[68] Сигаева Н.Н., Колесов С.В., Назаров П.В., Вильданова Р.Р. Химическая модификация гиалуроновой кислоты и ее применение в медицине//Вестник Башкирского университета. 2012. Т. 17. № 3. С. 1220–1241.

[69] Zhu Y, Hu J, Yu T, et al. High molecular weight hyaluronic acid inhibits fibrosis of endometrium. Med Sci Monit. 2016;22:3438–3445. DOI: 10.12659/msm.896028

[70] Zhu Y., Hu J., Yu T. et al. High molecular weight hyaluronic acid inhibits fibrosis of endometrium//Med. Sci. Monit. 2016. Vol. 22. P. 3438–3445. DOI: 10.12659/msm.896028

[71] Semenova EF, Polyakova AA, Agabalaeva KO, et al. Development of some stages of technology of microbial synthesis. Belgorod State University Scientific Bulletin Natural Sciences. 2018;42(3):297–307. DOI: 10.18413/2075-4671-2018-42-3-297-307

[72] Semenova E.F., Polyakova A.A., Agabalaeva K.O. et al. Development of some stages of technology of microbial synthesis//Belgorod State University Scientific Bulletin Natural Sciences 2018. Vol. 42. No. 3. P. 297–307. DOI: 10.18413/2075-4671-2018-42-3-297-307

[73] Chapple CR, Haab F, Cervigni M, et al. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Eur Urol. 2005;48(3):488–494. DOI: 10.1016/j.eururo.2005.05.007

[74] Chapple C.R., Haab F., Cervigni M. et al. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence//Eur. Urol. 2005. Vol. 48. No. 3. P. 488–494. DOI: 10.1016/j.eururo.2005.05.007

[75] Apolikhina IA, Saidova AS, Makhmedzhanova FN. Use of volume-forming drugs to treat female stress urinary incontinence. Obstetrics and gynecology. 2011;(7–1):21–24. (In Russ.)

[76] Аполихина И.А., Саидова А.С., Махмеджанова Ф.Н. Применение объемообразующих средств для лечения стрессового недержания мочи у женщин//Акушерство и гинекология. 2011. No. 7–1. С. 21–24.

[77] Lightner D, Rovner E, Corcos J, et al. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology. 2009;74(4):771–775. DOI: 10.1016/j.urology.2009.05.034

[78] Lightner D., Rovner E., Corcos J. et al. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically//Urology. 2009. Vol. 74. No. 4. P. 771–775. DOI: 10.1016/j.urology.2009.05.034

[79] Elzayat EA, Karsenty G, Bismar TA, Corcos J. Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(2):247–252. DOI: 10.1007/s00192-007-0414-9

[80] Elzayat E.A., Karsenty G., Bismar T.A., Corcos J. Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats//Int. Urogynecol. J. Pelvic. Floor. Dysfunct. 2008. Vol. 19. No. 2. P. 247–252. DOI: 10.1007/s00192-007-0414-9

[81] Burkhard FC, Bosch JLHR, Cruz F, et al. EAU Guidelines on Urinary Incontinence in Adults. European Association of Urology. 2020. [cited 2021 July 1]. Available from: https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Urinary-Incontinence-2020.pdf

[82] Burkhard F.C., Bosch J.L.H.R., Cruz F. et al. EAU guidelines on urinary incontinence in adults. European Association of Urology. 2020. [дата обращения 1.07.2021]. Доступ по ссылке: https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Urinary-Incontinence-2020.pdf

[83] Zakirova GSh, Gubanova EI, Gladko VV, et al. A randomized study of the safety and effectiveness of products based on stabilized hyaluronic acid for the correction of involutional changes in face and neck. Russian Journal of Skin and Venereal Diseases. 2018;21(1):53–60. (In Russ.). DOI: 10.18821/1560-9588-2018-21-1-51-53-60

[84] Закирова Г.Ш., Гладько В.В., Губанова Е.И. и др. Рандомизированное исследование безопасности и эффективности препаратов на основе стабилизированной гиалуроновой кислоты для коррекции инволюционных изменений кожи лица и шеи//Российский журнал кожных и венерических болезней. 2018. Т. 21. № 1. С. 53–60. DOI: 10.18821/1560-9588-2018-21-1-51-53-60

[85] Watad A, Quaresma M, Bragazzi NL, et al. The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry. Clin Rheumatol. 2018;37(2):483–493. DOI: 10.1007/s10067-017-3748-9

[86] Watad A., Quaresma M., Bragazzi N.L. et al. The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry//Clin. Rheumatol. 2018. Vol. 37. No. 2. P. 483–493. DOI: 10.1007/s10067-017-3748-9

[87] Apolikhina IA, Sokolova AV, Saidova AC, Gorbunova EA. Autologous platelet-rich plasma combined with hyaluronic acid is a new method of minimally invasive treatment of stress urinary incontinence in women. Medicinskij Sovet. 2018(13):16–20 (In Russ.). DOI: 10.21518/2079-701X-2018-13-16-20

[88] Аполихина И.А., Соколова А.В., Саидова А.С., Горбунова Е.А. Аутологичная плазма, обогащенная тромбоцитами, в сочетании с гиалуроновой кислотой — новый метод малоинвазивного лечения стрессового недержания мочи у женщин//Медицинский совет. 2018. № 13. С. 16–20. DOI: 10.21518/2079-701X-2018-13-16-20

[89] Rusina EI. Effectivnost’ parauretralnogo vvedeniya gialuronovoy kisloti pri stressovom nederzanii mochi u zhenshchin. In: International Congress “Operative Gynecology – Advanced Technologies” Overlook – 24-28 October 2018. St. Petersburg; 2018:39–40. (In Russ.). [cited 2021 July 1]. Available from: https://drive.google.com/file/d/16LZb89IA5qXuMINERxZsPh6eGJ584Z11/view

[90] Русина Е.И. Эффективность парауретрального введения гиалуроновой кислоты при стрессовом недержании мочи у женщин//Материалы 9-го международного научного конгресса «Оперативная гинекология — новые технологии». 24–28 октября 2018 г. Санкт-Петербург, 2018. С. 39–49. [дата обращения 1.07.2021]. Доступ по ссылке: https://drive.google.com/file/d/16LZb89IA5qXuMINERxZsPh6eGJ584Z11/view

[91] Leone Roberti Maggiore U, Bogani G, Meschia M, et al. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2015;189:48–54. DOI: 10.1016/j.ejogrb.2015.03.025

[92] Leone Roberti Maggiore U., Bogani G., Meschia M. et al. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis//Eur. J. Obstet. Gynecol. Reprod. Biol. 2015. Vol. 189. P. 48–54. DOI: 10.1016/j.ejogrb.2015.03.025

[93] Petros PE, Ulmsten UI. An integral theory and its method for the diagnosis and management of female urinary incontinence. Scand J Urol Nephrol Suppl. 1993;153:1–93.

[94] Petros P.E., Ulmsten U.I. An integral theory and its method for the diagnosis and management of female urinary incontinence//Scand. J. Urol. Nephrol. Suppl. 1993. Vol. 153. P. 1–93.

[95] DeLancey JO, Trowbridge ER, Miller JM, et al. Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol. 2008;179(6):2286–2290. DOI: 10.1016/j.juro.2008.01.098

[96] DeLancey J.O., Trowbridge E.R., Miller J.M. et al. Stress urinary incontinence: relative importance of urethral support and urethral closure pressure//J. Urol. 2008. Vol. 179. No. 6. P. 2286–2290. DOI: 10.1016/j.juro.2008.01.098

[97] Macevoy HJ. Notes on the arrangement and function of the cell groups in the sacral region of the spinal cord. (Journ. Nerv. Ment. Dis., August, 1899.) Onuf, B. Journal of Mental Science. 1900;46(194):563–563. DOI: 10.1192/bjp.46.194.563

[98] Macevoy H.J. Notes on the arrangement and function of the cell groups in the sacral region of the spinal cord. (Journ. Nerv. Ment. Dis., August, 1899.) Onuf, B//Journal of Mental Science. 1900. Vol. 46. No. 194. P. 563–563. DOI: 10.1192/bjp.46.194.563

[99] McGuire EJ, Lytton B, Kohorn EI, Pepe V. The value of urodynamic testing in stress urinary incontinence. J Urol. 1980;124(2):256–258. DOI: 10.1016/s0022-5347(17)55396-3

[100] McGuire E.J., Lytton B., Kohorn E.I., Pepe V. The value of urodynamic testing in stress urinary incontinence//J. Urol. 1980. Vol. 124. No. 2. P. 256–258. DOI: 10.1016/s0022-5347(17)55396-3

[101] McGuire EJ. Urodynamic findings in patients after failure of stress incontinence operations. Prog Clin Biol Res. 1981;78:351–360.

[102] McGuire E.J. Urodynamic findings in patients after failure of stress incontinence operations//Prog. Clin. Biol. Res. 1981. Vol. 78. P. 351–360.

[103] Kuhn A, Stadlmayr W, Lengsfeld D, Mueller MD. Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(6):817–821. DOI: 10.1007/s00192-007-0535-1

[104] Kuhn A., Stadlmayr W., Lengsfeld D., Mueller M.D. Where should bulking agents for female urodynamic stress incontinence be injected?//Int. Urogynecol. J. Pelvic. Floor. Dysfunct. 2008. Vol. 19. No. 6. P. 817–821. DOI: 10.1007/s00192-007-0535-1

[105] Steele AC, Kohli N, Karram MM. Periurethral collagen injection for stress incontinence with and without urethral hypermobility. Obstet Gynecol. 2000;95(3):327–331. DOI: 10.1016/s0029-7844(99)00568-2

[106] Steele A.C., Kohli N., Karram M.M. Periurethral collagen injection for stress incontinence with and without urethral hypermobility//Obstet. Gynecol. 2000. Vol. 95. No. 3. P. 327–331. DOI: 10.1016/s0029-7844(99)00568-2

[107] Bent AE, Foote J, Siegel S, et al. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol. 2001;166(4):1354–1357. DOI: 10.1016/S0022-5347(05)65768-0

[108] Bent A.E., Foote J., Siegel S. et al. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility//J. Urol. 2001. Vol. 166. No. 4. P. 1354–1357. DOI: 10.1016/S0022-5347(05)65768-0

[109] Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary incontinence: AUA/SUFU Guideline. J Urol. 2017;198(4):875–883. DOI: 10.1016/j.juro.2017.06.061

[110] Kobashi K.C., Albo M.E., Dmochowski R.R. et al. Surgical treatment of female stress urinary incontinence: AUA/SUFU Guideline//J. Urol. 2017. Vol. 198. No. 4. P. 875–883. DOI: 10.1016/j.juro.2017.06.061

[111] Klinicheskie rekomendacii. Nederzhanie mochi. 2020. Utverzhdeny Minzdravom RF (01.06.2020). (In Russ.). [cited 2021 July 1]. Available from: http://disuria.ru/_ld/7/730_kr20N39p3R32mz.pdf

[112] Клинические рекомендации. Недержание мочи. 2020. Утверждены Минздравом РФ (01.06.2020). [дата обращения 1.07.2021]. Доступ по ссылке: http://disuria.ru/_ld/7/730_kr20N39p3R32mz.pdf

[113] Koski ME, Enemchukwu EA, Padmanabhan P, et al. Safety and efficacy of sling for persistent stress urinary incontinence after bulking injection. Urology. 2011;77(5):1076–1080. DOI: 10.1016/j.urology.2010.10.010

[114] Koski M.E, Enemchukwu E.A., Padmanabhan P. et al. Safety and efficacy of sling for persistent stress urinary incontinence after bulking injection//Urology. 2011. Vol. 77. No. 5. P. 1076–1080. DOI: 10.1016/j.urology.2010.10.010.

RIGHTS & PERMISSIONS

Eсо-Vector